This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC2021 Conference Programme



Guidelines into Practice: Practical tips & approaches for CKD management in people with and without diabetes

11 Nov 2021
Heart & Kidney Clinic

Diabetic Kidney disease (DKD) is a leading cause of end stage kidney disease (ESKD) and premature cardiovascular disease. New treatments have demonstrated reduction in progression of DKD, prevention of ESKD and CVD in people with DKD.
This session will give an update on recent national and international guidelines and treatment recommendations for people with DKD.

  • Diabetic Kidney disease (DKD) affects 40% of people with diabetes. DM
  • There are new treatments that reduce risk and progression of DKD which operate independent of changes in blood glucose control.
  • The combination of DKD and CVD a common clinical challenge that needs a new coordinated care pathway


Diamond Sponsor

  • AstraZeneca


Platinum Sponsor

  • Abbott


Platinum Sponsor

  • Dexcom


Platinum Sponsor

  • Novo Nordisk


Platinum Sponsor

  • Viatris


Gold Sponsor

  • Eli Lilly


Gold Sponsor

  • Insulet


Silver Sponsor

  • Sanofi


Registration Sponsor

  • Viatris